BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30620287)

  • 1. Cysteine-rich protein 61 as a novel biomarker in systemic lupus erythematosus-associated pulmonary arterial hypertension.
    Fan Y; Zhao J; Qian J; Hao Y; Wang Q; Gao L; Li M; Zeng X; Zhang Z
    Clin Exp Rheumatol; 2019; 37(4):623-632. PubMed ID: 30620287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells.
    Gao L; Fan Y; Hao Y; Yuan P; Liu D; Jing Z; Zhang Z
    Int J Med Sci; 2017; 14(9):820-828. PubMed ID: 28824319
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.
    Lin J; Li N; Chen H; Liu C; Yang B; Ou Q
    Medicine (Baltimore); 2015 May; 94(19):e834. PubMed ID: 25984669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic and prognostic value of growth differentiation factor-15 in systemic lupus erythematosus-associated pulmonary arterial hypertension.
    Qian J; Ding Y; Yang X; Wang Q; Zhao J; Liu Y; Tian Z; Wang Y; Li M; Zeng X
    Pulm Circ; 2023 Jan; 13(1):e12195. PubMed ID: 36788942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Guo L; Li M; Chen Y; Wang Q; Tian Z; Pan S; Zeng X; Ye S
    Arthritis Rheumatol; 2015 Sep; 67(9):2394-402. PubMed ID: 26018988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry.
    Hachulla E; Jais X; Cinquetti G; Clerson P; Rottat L; Launay D; Cottin V; Habib G; Prevot G; Chabanne C; Foïs E; Amoura Z; Mouthon L; Le Guern V; Montani D; Simonneau G; Humbert M; Sobanski V; Sitbon O;
    Chest; 2018 Jan; 153(1):143-151. PubMed ID: 28851621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
    Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X
    Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.
    Pudasaini B; Yang GL; Yang C; Guo J; Yuan P; Wen-Lan Y; Zhang R; Wang L; Zhao QH; Gong SG; Jiang R; Chen TX; Wei X; Liu JM
    BMC Cardiovasc Disord; 2018 Mar; 18(1):56. PubMed ID: 29566672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study.
    Chen HA; Hsu TC; Yang SC; Weng CT; Wu CH; Sun CY; Lin CY
    Arthritis Res Ther; 2019 Mar; 21(1):82. PubMed ID: 30917868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.
    Xu SZ; Yan Liang ; Li XP; Li XM; Shuai ZW; Leng RX; Pan HF; Ye DQ
    Clin Rheumatol; 2018 Jun; 37(6):1547-1553. PubMed ID: 29520672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and prognosis in systemic lupus erythematosus-associated pulmonary arterial hypertension based on consensus clustering and risk prediction model.
    Dai M; Zhang C; Li C; Wang Q; Gao C; Yue R; Yao M; Su Z; Zheng Z
    Arthritis Res Ther; 2023 Aug; 25(1):155. PubMed ID: 37612772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.
    Li M; Wang Q; Zhao J; Li Z; Ye Z; Li C; Li X; Zhu P; Wang Z; Zheng Y; Li X; Zhang M; Tian Z; Liu Y; He J; Zhang F; Zhao Y; Zeng X;
    Lupus; 2014 Sep; 23(10):1085-91. PubMed ID: 24651670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nailfold capillaroscopy as a risk factor for pulmonary arterial hypertension in systemic lupus erythematosus patients.
    Donnarumma JFS; Ferreira EVM; Ota-Arakaki J; Kayser C
    Adv Rheumatol; 2019 Jan; 59(1):1. PubMed ID: 30657102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis.
    Fan Y; Yang X; Zhao J; Sun X; Xie W; Huang Y; Li G; Hao Y; Zhang Z
    Arthritis Res Ther; 2019 May; 21(1):123. PubMed ID: 31113467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial stiffness, antiphospholipid antibodies, and pulmonary arterial hypertension in systemic lupus erythematosus.
    Lee JH; Im Cho K
    J Cardiol; 2014 Dec; 64(6):450-5. PubMed ID: 24755203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus.
    Lian F; Chen D; Wang Y; Ye Y; Wang X; Zhan Z; Xu H; Liang L; Yang X
    Rheumatol Int; 2012 Jun; 32(6):1727-31. PubMed ID: 21437686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients.
    Huang C; Li M; Liu Y; Wang Q; Guo X; Zhao J; Lai J; Tian Z; Zhao Y; Zeng X
    Medicine (Baltimore); 2016 Mar; 95(10):e2761. PubMed ID: 26962774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
    Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH
    Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coupling Factor 6 Is Upregulated in Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
    Li N; Yin J; Cai W; Liu J; Zhang N; Yan S; Song L; Li X
    Am J Med Sci; 2016 Dec; 352(6):631-636. PubMed ID: 27916219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Study Identified HLA-DQA1 as a Novel Genetic Risk of Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Qian J; Chen Y; Yang X; Wang Q; Zhao J; Deng X; Ding Y; Li S; Liu Y; Tian Z; Shen J; Liao Q; Wang Y; Zuo X; Zhang X; Li M; Cui Y; Yu X; Zeng X
    Arthritis Rheumatol; 2023 Dec; 75(12):2207-2215. PubMed ID: 37382296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.